TY - JOUR
T1 - Hyperbaric Oxygen in Combination with Epigallocatechin-3-Gallate Synergistically Enhance Recovery from Spinal Cord Injury in Rats
AU - Alshahrani, Shadia Hamoud
AU - Almajidi, Yasir Qasim
AU - Hasan, Ekhlas Khammas
AU - Musad Saleh, Ebraheem Abdu
AU - Alsaab, Hashem O.
AU - Pant, Ruby
AU - Hassan, Zahraa F.
AU - Al-Hasnawi, Shaker Shanawa
AU - Romero-Parra, Rosario Mireya
AU - Mustafa, Yasser Fakri
N1 - Funding Information:
This work was supported by the Baghdad College of Medical Sciences (grant number: 14725 ).
Publisher Copyright:
© 2023 IBRO
PY - 2023/9/1
Y1 - 2023/9/1
N2 - Spinal cord injury (SCI) following trauma is a devastating neurological event that can lead to loss of sensory and motor functions. However, the most effective measures to prevent the spread of damage are treatment measures in the early stages. Currently, we investigated the combined effects of hyperbaric oxygen (HBO) along with epigallocatechin-3-gallate (EGCG) in the recovery of SCI in rats. Ninety male mature Sprague-Dawley rats were randomly planned into five equal groups (n = 18). In addition to sham group that only underwent laminectomy, SCI rats were allocated into 4 groups as follows: control group; HBO group; EGCG group; and HBO + EGCG group. Tissue samples at the lesion site were obtained for stereological, immunohistochemical, biochemical, and molecular evaluation. In addition, behavioral tests were performed to assess of neurological functions. The finding indicated that the stereological parameters, antioxidant factors (CAT, GSH, and SOD), IL-10 gene expression levels and neurological functions were considerably increased in the treatment groups in comparison with control group, and these changes were more obvious in the HBO + EGCG group (P < 0.05). On the other hand, we observed that the density of apoptotic cells and gliosis, the biochemical levels of MDA and the expression levels of inflammatory genes (TNF-α and IL-1β) in the treatment groups, especially the HBO + EGCG group, were considerably reduced in comparison with control group (P < 0.05). We conclude that co-administration of HBO and EGCG has a synergistic neuroprotective effects in animals undergoing SCI.
AB - Spinal cord injury (SCI) following trauma is a devastating neurological event that can lead to loss of sensory and motor functions. However, the most effective measures to prevent the spread of damage are treatment measures in the early stages. Currently, we investigated the combined effects of hyperbaric oxygen (HBO) along with epigallocatechin-3-gallate (EGCG) in the recovery of SCI in rats. Ninety male mature Sprague-Dawley rats were randomly planned into five equal groups (n = 18). In addition to sham group that only underwent laminectomy, SCI rats were allocated into 4 groups as follows: control group; HBO group; EGCG group; and HBO + EGCG group. Tissue samples at the lesion site were obtained for stereological, immunohistochemical, biochemical, and molecular evaluation. In addition, behavioral tests were performed to assess of neurological functions. The finding indicated that the stereological parameters, antioxidant factors (CAT, GSH, and SOD), IL-10 gene expression levels and neurological functions were considerably increased in the treatment groups in comparison with control group, and these changes were more obvious in the HBO + EGCG group (P < 0.05). On the other hand, we observed that the density of apoptotic cells and gliosis, the biochemical levels of MDA and the expression levels of inflammatory genes (TNF-α and IL-1β) in the treatment groups, especially the HBO + EGCG group, were considerably reduced in comparison with control group (P < 0.05). We conclude that co-administration of HBO and EGCG has a synergistic neuroprotective effects in animals undergoing SCI.
KW - EGCG
KW - epigallocatechin-3-gallate
KW - hyperbaric oxygen
KW - spinal cord injury
UR - http://www.scopus.com/inward/record.url?scp=85166277221&partnerID=8YFLogxK
U2 - 10.1016/j.neuroscience.2023.07.015
DO - 10.1016/j.neuroscience.2023.07.015
M3 - Original Article
C2 - 37499782
AN - SCOPUS:85166277221
SN - 0306-4522
VL - 527
SP - 52
EP - 63
JO - Neuroscience
JF - Neuroscience
ER -